Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 11/20 | 0.38 |
| ▸ | PPARG | P37231 | 10/20 | 0.38 |
| ▸ | S1PR5 | Q9H228 | 6/20 | 0.34 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.34 |
| ▸ | FABP4 | P15090 | 1/20 | 0.34 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.33 |
| ▸ | PPARD | Q03181 | 4/20 | 0.32 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.32 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7974184 | 0.89 | PPARG (0.41) | PPARAPPARGPTGDR2PPARD | |
| SCHEMBL7521989 | 0.86 | S1PR5 (0.37) | S1PR5S1PR4FABP4PPARD | |
| SCHEMBL7527054 | 0.74 | PPARD (0.38) | PPARAPPARGPTGDR2PPARD | |
| SCHEMBL7523863 | 0.73 | TP53 (0.44) | PTGDR2PPARD | |
| SCHEMBL7974188 | 0.70 | PPARG (0.37) | PPARAPPARGS1PR5S1PR4FABP4 | |
| SCHEMBL7962805 | 0.62 | ALDH1A1 (0.35) | PPARAPPARGPTGDR2PPARD | |
| SCHEMBL7974327 | 0.61 | PPARA (0.42) | PPARAPPARGFABP4PTGDR2PPARD | |
| SCHEMBL7962753 | 0.61 | PPARA (0.38) | PPARAPPARGFABP4PPARD | |
| SCHEMBL8935913 | 0.60 | PPARG (0.77) | PPARAPPARGAKR1C3AKR1C2 | |
| SCHEMBL8935921 | 0.60 | PPARG (0.77) | PPARAPPARGAKR1C3AKR1C2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6248766-B1 | CARDIOVASCULAR DISORDERS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-06-19 | — | — | US | disclosed |